![](https://endpts.com/wp-content/uploads/2021/08/Cosmo-Feilding-Mellen-Beckley-Psytech-tile-scaled.jpg)
Cosmo Feilding Mellen, Beckley Psytech CEO
Magic mushrooms and 'toad venom' get this British biotech an oversubscribed Series B
A new psychedelics player burst onto the scene Monday with a hefty Series B, aiming to refashion two well-known drugs into therapies for crippling headaches …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.